Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treatment effects of antithrombin in septic patients with disseminated intravascular coagulation (DIC)

Trial Profile

Treatment effects of antithrombin in septic patients with disseminated intravascular coagulation (DIC)

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Nov 2012

At a glance

  • Drugs Antithrombin III (Primary)
  • Indications Disseminated intravascular coagulation; Embolism and thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
    • 21 Dec 2007 Status change
    • 06 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top